Checkpoint Therapeutics CKPT 深 沪
已收盘 05-30 16:00:00 美东时间
4.26
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 4.26
- 总市值 3.88亿
- 52周最高 4.50
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.47
- 委 比 0.00%
- 总股本 9102.64万
- 历史最高 10.50
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.502
- 每 手 1
- 风险率 0.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Check Point Software Technologies Recognized as a Best Company to Work For by U.S. News & World Report
Check Point Software Technologies has been named one of the Best Companies to Work For by U.S. News & World Report for 2025-2026, also recognized in the IT industry. The company is praised for fostering innovation, inclusion, and growth, aligning with its mission to attract and retain top talent globally.
06-02 13:00
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
03-11 21:14
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Nasdaq Composite fall...
03-11 01:09
Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study
Amgen and Kyowa Kirin's rocatinlimab showed strong efficacy in Phase 3 trials for atopic dermatitis, achieving key endpoints in IGNITE and SHUTTLE studies.
03-11 00:50
Nasdaq Dips Over 3%; Checkpoint Therapeutics Shares Jump
U.S. stocks traded lower this morning, with the Dow Jones index falling around ...
03-10 22:50
HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $20 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $20 price target.
2024-09-17 01:29
Check Point Software To Acquire Cyberint To Transform Security Operations; No Financial Terms Of The Transaction Disclosed
Check Point® Software Technologies Ltd. (NASDAQ:CHKP), a leading cyber security platform provider, signs a definitive agreement to acquire Cyberint Technologies Ltd., a pioneering provider of External Risk Management solutions. This will significantly enhance Check Point's Security Operations Center...
2024-08-27 20:18
Checkpoint Therapeutics Unveils Secondary Sale of Securities
05:39 PM EDT, 08/19/2024 (MT Newswires) -- Checkpoint Therapeutics (CKPT) disclosed a secondary sale late Monday of up to roughly 5.9 million shares underlying common stock warrants and 351,220 shares underlying placement agent warrants. The company said the selling shareholders may offer, sell, or ...
2024-08-20 05:39
